Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-25 @ 4:42 AM
NCT ID:
NCT04847518
Eligibility Criteria:
Inclusion Criteria:
* Laboratory confirmed (SARS-Cov-2 PCR-positive test) mild COVID-19 infection (in the last three days),
* COVID-19 patient in stable, moderate condition (i.e., not requiring Intensive Care Unit (ICU) admission).
* Subjects must be under observation or admitted to a controlled facility or hospital (home quarantine is not sufficient).
* Able to take medication alone
* Able to give informed consent.
Exclusion Criteria:
* Pulmonary diseases
* Chronic pulmonary diseases
* Chronic rhinosinusitis
* Patient admitted already under invasive mechanical ventilation;
* The patient admitted with the severe acute respiratory syndrome and diagnosed with an etiologic agent other than Covid 19;
* Renal failure requiring dialysis or creatinine ≥ 2.0mg/dl;
* Tube feeding or parenteral nutrition.
* Respiratory decompensation requiring mechanical ventilation.
* Uncontrolled diabetes type 2.
* Hypertension stage 3,
* Autoimmune disease.
* Pregnant or lactating women.
* Patients are taking antibiotics for a reason other than COVID-19 at enrollment.
* Has a chronically weakened immune system (AIDS, lymphoma, chemo-radio- corticosteroid therapy, immunosuppressive pathology);
* Patients treated with chemo-radio-corticosteroid therapy in the last six months.
* Patients with active cancer.
* Taking immunosuppressive drugs (e.g., anti-rejection treatment after organ transplant);
* Already participating in another clinical trial;
* Has any other condition that would prevent safe participation in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04847518
Study Brief:
Protocol Section:
NCT04847518